The Effects of Direct-to-Consumer Antidepressant Advertisements on Young Adults
Abstract
Depression, one of the most frequently diagnosed conditions in the United States, affects more than 10% of the American population. Accordingly, direct-to-consumer (DTC) advertisements for antidepressant drug products have become prevalent in American media. Depression is especially widespread among college students, with 30% of young adults reporting depressive symptoms. These young adults, in particular, seem to be susceptible to the viewpoints expressed in antidepressant advertisement campaigns. As a result, these DTC promotions have the potential to shape young adults’ views on depression and antidepressant drug therapy. Specifically, the biomedical theory of depression, depression as a predominantly female disease, and the “magic bullet” capabilities of antidepressants are concepts touted in these advertisements, presenting a skewed representation of the condition to young adults.
Key Words: Advertising; Antidepressants; Biomedical Theory; Depression; Direct-to-Consumer Advertisements; FDA; Gender Gap; Magic Bullet; Young Adults
Downloads
Published
Issue
Section
License
Authors retain copyright and grant the journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.